Silexion Therapeutics Corp

SLXN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
81
SEC Filings

Business Summary

PART I . Unless the context otherwise requires, in this Business section, the terms we, us and our generally refer to: (i) for the period following the Closing of the Business Combination on August 15, 2024, Silexion Therapeutics Corp (formerly known as Biomotion Sciences), a Cayman Islands exempted company (Silexion) and its consolidated subsidiaries, including Silexion Therapeutics Ltd., an Israeli company (Silexion Israel), through which our business is primarily conducted, and, (ii) with res...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSLXNdiscussed_in_filing Cybersecurity
topic_mentionSLXNdiscussed_in_filing Trusted Computing
topic_mentionSLXNdiscussed_in_filing Blockchain & Crypto
topic_mentionSLXNdiscussed_in_filing Regulation
topic_mentionSLXNdiscussed_in_filing Healthcare & Bio
topic_mentionSLXNdiscussed_in_filing Platform & Ecosystem
topic_mentionSLXNdiscussed_in_filing Cybersecurity
topic_mentionSLXNdiscussed_in_filing Trusted Computing
topic_mentionSLXNdiscussed_in_filing Blockchain & Crypto
topic_mentionSLXNdiscussed_in_filing Regulation
topic_mentionSLXNdiscussed_in_filing Healthcare & Bio
topic_mentionSLXNdiscussed_in_filing Platform & Ecosystem
topic_mentionSLXNdiscussed_in_filing Cybersecurity
topic_mentionSLXNdiscussed_in_filing Trusted Computing
topic_mentionSLXNdiscussed_in_filing Blockchain & Crypto
topic_mentionSLXNdiscussed_in_filing Regulation
topic_mentionSLXNdiscussed_in_filing Healthcare & Bio
topic_mentionSLXNdiscussed_in_filing Platform & Ecosystem
topic_mentionSLXNdiscussed_in_filing Cybersecurity
topic_mentionSLXNdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001178913-26-000953EDGAR98K words
2025-03-182024-12-310001178913-25-000887EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001178913-25-003753EDGAR32K words
2025-08-122025-06-300001178913-25-002804EDGAR—
2025-05-132025-03-310001178913-25-001761EDGAR—
2024-11-142024-09-300001178913-24-003686EDGAR—
2024-08-292024-06-300001213900-24-073934EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001178913-26-001722EDGAR1K words
2026-03-240001178913-26-001615EDGAR—
2026-03-230001178913-26-001597EDGAR—
2026-02-030001178913-26-000289EDGAR—
2026-01-060001178913-26-000067EDGAR—
2025-12-160001178913-25-004067EDGAR—
2025-12-020001178913-25-003981EDGAR—
2025-11-250001178913-25-003949EDGAR—
2025-11-120001178913-25-003756EDGAR—
2025-09-300001178913-25-003444EDGAR—

81 total filings indexed. 64 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002022416
TickerSLXN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedE9

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6c9444dd2156ec65163967230c8aab05db3943fa4047b752ba165c5e1d1a8c53
parent: b49b28cfe4c5f80ac2bf70c532d36bd9443f7c375845bcabc9b66167309e6793
content hash: 05cbce26f25afc2939110867caa43ad9ea16e2c3fe15514cc254bf79feedca37
signed: 2026-04-13T04:47:29.488Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf